The chronic obstructive pulmonary disease-asthma overlap syndrome.
暂无分享,去创建一个
[1] B. Burrows,et al. Comparisons of asthma, emphysema, and chronic bronchitis diagnoses in a general population sample. , 2015, The American review of respiratory disease.
[2] S. Beavers,et al. Active Asthma and the Prevalence of Physician-Diagnosed COPD , 2014, Lung.
[3] Edwin J R van Beek,et al. The clinical and genetic features of COPD-asthma overlap syndrome , 2014, European Respiratory Journal.
[4] G. Valdivia,et al. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma. , 2014, Chest.
[5] Jing Gao,et al. Differences in plasma and sputum biomarkers between COPD and COPD–asthma overlap , 2013, European Respiratory Journal.
[6] D. Mannino,et al. COPD Surveillance—United States, 1999-2011 , 2013, Chest.
[7] B. Morrissey,et al. The asthma–chronic obstructive pulmonary disease overlap syndrome: pharmacotherapeutic considerations , 2013, Expert review of clinical pharmacology.
[8] L. Akinbami,et al. National surveillance of asthma: United States, 2001-2010. , 2012, Vital & health statistics. Series 3, Analytical and epidemiological studies.
[9] J. Soriano,et al. Consensus document on the overlap phenotype COPD-asthma in COPD. , 2012, Archivos de bronconeumologia.
[10] M. Miravitlles,et al. The overlap phenotype: the (missing) link between asthma and COPD , 2012, Multidisciplinary Respiratory Medicine.
[11] D. Cockcroft,et al. Past, present and future uses of methacholine testing , 2012, Expert review of respiratory medicine.
[12] K. Kubo,et al. Sputum eosinophilia can predict responsiveness to inhaled corticosteroid treatment in patients with overlap syndrome of COPD and asthma , 2012, International journal of chronic obstructive pulmonary disease.
[13] M. Weatherall,et al. Towards individualised medicine for airways disease: identifying clinical phenotype groups , 2012, European Respiratory Journal.
[14] M. Schivo,et al. The Asthma-COPD Overlap Syndrome: A Common Clinical Problem in the Elderly , 2011, Journal of allergy.
[15] Joyce D. Schroeder,et al. The clinical features of the overlap between COPD and asthma , 2011, Respiratory research.
[16] D. Postma,et al. Asthma and chronic obstructive pulmonary disease: common genes, common environments? , 2011, American journal of respiratory and critical care medicine.
[17] J. Walusiak‐Skorupa,et al. Faculty Opinions recommendation of COPD in never smokers: results from the population-based burden of obstructive lung disease study. , 2011 .
[18] L. Fabbri,et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up. , 2010, The Journal of allergy and clinical immunology.
[19] Jon G Ayres,et al. COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis , 2010, Thorax.
[20] M. Weatherall,et al. Time to define the disorders of the syndrome of COPD , 2009, The Lancet.
[21] P. Gibson,et al. The overlap syndrome of asthma and COPD: what are its features and how important is it? , 2009, Thorax.
[22] G. Anderson,et al. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease , 2008, The Lancet.
[23] Anand A. Dalal,et al. Burden of concomitant asthma and COPD in a Medicaid population. , 2008, Chest.
[24] M. Decramer,et al. Bronchodilator responsiveness in patients with COPD , 2008, European Respiratory Journal.
[25] D. Niewoehner,et al. Exhaled nitric oxide, systemic inflammation, and the spirometric response to inhaled fluticasone propionate in severe chronic obstructive pulmonary disease: A prospective study , 2008, Therapeutic advances in respiratory disease.
[26] P. Barnes,et al. Inflammation, Oxidative Stress and Systemic Effects in Mild Chronic Obstructive Pulmonary Disease , 2007, International journal of immunopathology and pharmacology.
[27] R. Perng,et al. Characteristics of airway inflammation and bronchodilator reversibility in COPD: a potential guide to treatment. , 2004, Chest.
[28] Stefano Guerra,et al. Asthma as a risk factor for COPD in a longitudinal study. , 2004, Chest.
[29] W. MacNee,et al. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper , 2004, European Respiratory Journal.
[30] P. Chanez,et al. Can endobronchial biopsy analysis be recommended to discriminate between asthma and COPD in routine practice? , 2004, Thorax.
[31] Joan B Soriano,et al. The proportional Venn diagram of obstructive lung disease: two approximations from the United States and the United Kingdom. , 2003, Chest.
[32] D. Postma,et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. , 2003, Thorax.
[33] L. Corbetta,et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.
[34] F. Rasmussen,et al. Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood. , 2002, American journal of respiratory and critical care medicine.
[35] D. Mannino. COPD: epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. , 2002, Chest.
[36] L. Fabbri,et al. Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.
[37] N. Zamel,et al. Unsuspected pseudophysiologic emphysema in chronic persistent asthma. , 2000, American journal of respiratory and critical care medicine.
[38] I. Pavord,et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial , 2000, The Lancet.
[39] N. Orie,et al. The dutch hypothesis , 2000, Chest.
[40] D. Postma,et al. Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.
[41] V. Backer,et al. Nonreversible airflow obstruction in life-long nonsmokers with moderate to severe asthma. , 1999, The European respiratory journal.
[42] C. Ulrik. Outcome of asthma: longitudinal changes in lung function. , 1999, The European respiratory journal.
[43] C. Reed. The natural history of asthma in adults: the problem of irreversibility. , 1999, The Journal of allergy and clinical immunology.
[44] J Vestbo,et al. A 15-year follow-up study of ventilatory function in adults with asthma. , 1998, The New England journal of medicine.
[45] P. Enright,et al. Peak flow lability: association with asthma and spirometry in an older cohort. , 1997, Chest.
[46] J. Stoller,et al. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. , 1994, Cleveland Clinic journal of medicine.
[47] P. Lange,et al. Decline of lung function in adults with bronchial asthma. , 1994, American journal of respiratory and critical care medicine.
[48] A. Rebuck,et al. Is the short-term response to inhaled beta-adrenergic agonist sensitive or specific for distinguishing between asthma and COPD? , 1994, Chest.
[49] S. Braman,et al. Asthma in the elderly. A comparison between patients with recently acquired and long-standing disease. , 1991, The American review of respiratory disease.
[50] A. Woolcock,et al. Rate of decline of lung function in subjects with asthma. , 1987, European journal of respiratory diseases.
[51] E. Schachter,et al. A prospective study of asthma in a rural community. , 1984, Chest.
[52] K. Finucane,et al. Asthma and irreversible airflow obstruction. , 1984, Thorax.
[53] H. Çalışır,et al. Biomass smoke exposure as a serious health hazard for women. , 2013, Tuberkuloz ve toraks.
[54] M. Dolhnikoff,et al. Impaired lung function in individuals chronically exposed to biomass combustion. , 2012, Environmental research.
[55] Sean Keenan,et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease - 2007 update. , 2007, Canadian respiratory journal.
[56] Charles A. Johnson,et al. Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. , 2004, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[57] I. Grzelewska-Rzymowska,et al. [Airway remodeling in asthma]. , 2003, Pneumonologia i alergologia polska.
[58] J. Hankinson,et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. , 2000, American journal of respiratory and critical care medicine.
[59] J. Connett,et al. Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.